Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.

ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.

Investigators studied recent trends in chain ownership, physician ownership, and medical directorship of dialysis facilities in the US.

An elderly man with immunoglobulin G4-related disease (IgG4-RD) with kidney involvement and monoclonal gammopathy was successfully treated with corticosteroid therapy. This case report was published ...

Delirium most common among those with intracerebral hemorrhage; more severe delirium tied to worse outcomes. (HealthDay News) — More than one in four critically ill patients with stroke experience ...

(HealthDay News) — Wildfire smoke exposure over time may increase the risk for heart failure, according to a study published in the July issue of the Journal of the American College of Cardiology.

However, incidence rates of vision-threatening diabetic retinopathy, diabetic macular edema, and proliferative diabetic retinopathy have decreased.

(HealthDay News) — Fecal microbiota analysis of pregnant women may provide early identification of those at risk for gestational diabetes, according to a study published online July 1 in Microbiology ...